Whipplewood Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05K Sell
2
-17
-89% -$9.54K ﹤0.01% 540
2026
Q1
$10.7K Buy
+19
New +$12.2K 0.01% 474
2025
Q3
Sell
-54
Closed -$29K 720
2025
Q2
$29K Sell
54
-98
-64% -$46.9K 0.02% 403
2025
Q1
$10.1K Buy
152
+133
+700% +$57.8K 0.01% 563
2024
Q4
$7.86K Buy
+19
New +$8.33K ﹤0.01% 597

Other funds holding IDXX

Whipplewood Advisors's IDXX Position: Q2 2026 in Review

Whipplewood Advisors reduced its Idexx Laboratories (IDXX) stake by 89% in Q2 2026, selling an estimated $9.54K and leaving 2 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #540.

Whipplewood Advisors first reported a position in IDXX in Q4 2024 and has held it in 5 quarters since. The position peaked at $29K in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Whipplewood Advisors held 2 shares of Idexx Laboratories worth $1.05K as of Q2 2026.
  • Whipplewood Advisors sold 17 Idexx Laboratories shares in Q2 2026, an estimated $9.54K.
  • Idexx Laboratories made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #540 holding.
  • Whipplewood Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 5 quarters since.
  • Whipplewood Advisors's Idexx Laboratories position peaked at $29K in Q2 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.